| Heparan sulfate proteoglycan is a mechanosensor on endothelial cells JA Florian, JR Kosky, K Ainslie, Z Pang, RO Dull, JM Tarbell Circulation research 93 (10), e136-e142, 2003 | 786 | 2003 |
| A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer N Cheng, R Watkins-Schulz, RD Junkins, CN David, BM Johnson, ... JCI insight 3 (22), 2018 | 219 | 2018 |
| In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants EM Bachelder, TT Beaudette, KE Broaders, JMJ Fréchet, MT Albrecht, ... Molecular pharmaceutics 7 (3), 826-835, 2010 | 157 | 2010 |
| Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing KM Ainslie, TA Desai Lab on a Chip 8 (11), 1864-1878, 2008 | 150 | 2008 |
| Acetalated dextran: a tunable and acid-labile biopolymer with facile synthesis and a range of applications EM Bachelder, EN Pino, KM Ainslie Chemical reviews 117 (3), 1915-1926, 2017 | 141 | 2017 |
| A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination RD Junkins, MD Gallovic, BM Johnson, MA Collier, R Watkins-Schulz, ... Journal of Controlled Release 270, 1-13, 2018 | 140 | 2018 |
| In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone KM Ainslie, SL Tao, KC Popat, H Daniels, V Hardev, CA Grimes, TA Desai Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2009 | 120 | 2009 |
| Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product KJ Kauffman, C Do, S Sharma, MD Gallovic, EM Bachelder, KM Ainslie ACS applied materials & interfaces 4 (8), 4149-4155, 2012 | 102 | 2012 |
| Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis AD Duong, S Sharma, KJ Peine, G Gupta, AR Satoskar, EM Bachelder, ... Molecular pharmaceutics 10 (3), 1045-1055, 2013 | 98 | 2013 |
| Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection CJ Batty, MT Heise, EM Bachelder, KM Ainslie Advanced drug delivery reviews 169, 168-189, 2021 | 91 | 2021 |
| Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery SA Meenach, YJ Kim, KJ Kauffman, N Kanthamneni, EM Bachelder, ... Molecular pharmaceutics 9 (2), 290-298, 2012 | 87 | 2012 |
| Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo RT Steipel, MD Gallovic, CJ Batty, EM Bachelder, KM Ainslie Materials Science and Engineering: C 105, 110070, 2019 | 84 | 2019 |
| Microfabricated Devices for Enhanced Bioadhesive Drug Delivery: Attachment to and Small‐Molecule Release Through a Cell Monolayer Under Flow KM Ainslie, RD Lowe, TT Beaudette, L Petty, EM Bachelder, TA Desai Small 5 (24), 2857-2863, 2009 | 83 | 2009 |
| Vascular smooth muscle cell glycocalyx influences shear stress-mediated contractile response KM Ainslie, JS Garanich, RO Dull, JM Tarbell Journal of applied physiology 98 (1), 242-249, 2005 | 82 | 2005 |
| Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression KJ Kauffman, N Kanthamneni, SA Meenach, BC Pierson, EM Bachelder, ... International journal of pharmaceutics 422 (1-2), 356-363, 2012 | 80 | 2012 |
| Acetalated dextran microparticles for codelivery of STING and TLR7/8 agonists MA Collier, RD Junkins, MD Gallovic, BM Johnson, MM Johnson, ... Molecular pharmaceutics 15 (11), 4933-4946, 2018 | 79 | 2018 |
| A microparticle platform for STING-targeted immunotherapy enhances natural killer cell-and CD8+ T cell-mediated anti-tumor immunity R Watkins-Schulz, P Tiet, MD Gallovic, RD Junkins, C Batty, ... Biomaterials 205, 94-105, 2019 | 77 | 2019 |
| Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses N Chen, MM Johnson, MA Collier, MD Gallovic, EM Bachelder, KM Ainslie Journal of Controlled Release 273, 147-159, 2018 | 77 | 2018 |
| PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis LM Webb, SA Amici, KA Jablonski, H Savardekar, AR Panfil, L Li, W Zhou, ... The Journal of Immunology 198 (4), 1439-1451, 2017 | 77 | 2017 |
| Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles KJ Peine, M Guerau-de-Arellano, P Lee, N Kanthamneni, M Severin, ... Molecular pharmaceutics 11 (3), 828-835, 2014 | 77 | 2014 |
Eric BachelderAssociate Professor of Pharmacy, University of North Carolina在 email.unc.edu 的电子邮件经过验证
